ea0011p362 | Diabetes, metabolism and cardiovascular | ECE2006
Kravariti M
, Naka KK
, Kazakos N
, Michalis LK
, Tsatsoulis A
, Kalantaridou S
Background: Women with PCOS carry cardiovascular (CV) risk factors, which may account for the increased CV risk. Oral contraception therapy using ethinyl-estradiol & cyproterone acetate (EE-CA) is administrated to normalize menstrual cycles and reduce serum androgen levels in women with PCOS. The aim of this study was to assess the effect of EE-CA on endothelial function in young, non-obese PCOS women.Methods: We studied 13 non-obese (body mass index...